Alprazolam (Xanax) Mega Study
Contents
Alprazolam (Xanax)
Alprazolam (Xanax)

Related

A
Count
A
Treatments
A
Effects
A
User Variables 1
A
Measurements 3

Tags

Alprazolam
Xanax
Alprazolam (Xanax)

Treatment Effectiveness

User reported effectiveness ratings Alprazolam (Xanax) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Tinnitus 0% 15% 8% 62% 15% 13
Anxiety 29% 46% 6% 16% 3% 417

Side Effects

User-reported side effects of Alprazolam (Xanax)

Side Effect Percent of Reports Alprazolam (Xanax)
Irritability 16%
Suicidal Thoughts 6%
Constipation 13%
Depression 23%
Dry Mouth 23%
Blurred Vision 14%
Convulsion 1%
Decreased Inhibitions 40%
Decreased Sex Drive 24%
Dizziness 26%
Drowsiness 62%
Forgetfulness 36%
High Blood Pressure 8%
Hot Flashes When Dosage Increased 2%
Hyperactivity 7%
Jaundice 2%
Light-Headedness 28%
Muscle Weakness 11%
Racing Thoughts 11%
Reduced Anxiety 86%
Reduced Panic 81%
Seizure 1%
Tremor 6%
Vomiting 2%
Watery Mouth 1%
Insomnia 12%
Nausea 8%

Below is the degree of change seen after Alprazolam (Xanax) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Alprazolam (Xanax) Info

Property Value
Variable Name Alprazolam (Xanax)
Aggregation Method SUM
Analysis Performed At 2020-10-07
Duration of Action 21 days
Filling Value 0
Kurtosis 20.678760351021
Mean 0.088235 count
Median 0 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 3
Number of Measurements (including those generated by tagged, joined, or child variables) 3
Public true
Onset Delay 30 minutes
Standard Deviation 0.37880570368042
Unit Count
User Variables 1
UPC 643307990577
Variable Category Treatments
Variable ID 92299
Variance 0.14349376114082